Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05336825 · ClinicalTrials.gov registry record · NA
CO2 Laser vs Lidocaine for Vestibulodynia in Premenopausal Women
A NA study, sponsored by Atlantic Health System.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT05336825 is a NA study that has completed, run by Atlantic Health System. The registered enrollment target is 10 participants.
The verdict
NCT05336825, a NA study, has completed, sponsored by Atlantic Health System.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
CO2 laser energy is currently used widely for the treatment of postmenopausal women who have vaginal atrophy due to the lack of estrogen. However, its effect on premenopausal women with hormonally-mediated vulvar vestibulodynia is unknown. This study seeks to evaluate the effect of CO2 laser on young women and compare it to topical lidocaine.
Interventions
- DEVICE CO2 laser
- DRUG Lidocaine patch 5%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2019-04-01 |
| Est. Completion | 2021-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05336825
The ClinicalTrials.gov registry entry for NCT05336825 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Atlantic Health System, which has 43 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which CO2 laser is the first listed.
NCT05336825 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05336825 about?
NCT05336825 is a clinical study titled "CO2 Laser vs Lidocaine for Vestibulodynia in Premenopausal Women". CO2 laser energy is currently used widely for the treatment of postmenopausal women who have vaginal atrophy due to the lack of estrogen. However, its effect on premenopausal women with hormonally-mediated vulvar vestibulodynia is unknown. This study seeks to evaluate the effect of CO2 laser on youn...
What is the current status of trial NCT05336825?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2019-04-01. Estimated completion is 2021-01-31.
What interventions are being tested in trial NCT05336825?
The interventions under investigation include: CO2 laser (DEVICE), Lidocaine patch 5% (DRUG).
Who is sponsoring clinical trial NCT05336825?
This trial is sponsored by Atlantic Health System, which has 43 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.